“Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.”, Ophthalmology, vol. 124, no. 12, pp. 1764-1777, 2017.
, “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
, “Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.”, Ophthalmology, vol. 123, no. 12, pp. 2554-2570, 2016.
, “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
, “Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.”, Ophthalmology, vol. 120, no. 1, pp. 140-50, 2013.
, “Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD.”, Invest Ophthalmol Vis Sci, vol. 53, no. 8, pp. 4626-33, 2012.
,